Selatinib
Modify Date: 2025-09-21 11:55:07
Selatinib structure
|
Common Name | Selatinib | ||
|---|---|---|---|---|
| CAS Number | 1275595-86-2 | Molecular Weight | 565.06 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 740.5±60.0 °C at 760 mmHg | |
| Molecular Formula | C29H26ClFN4O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 401.6±32.9 °C | |
Use of SelatinibSelatinib is a reversible and orally active dual EGFR and ErbB2 inhibitor with IC50s of 13 nM and 22.5 nM, respectively. Selatinib has anticancer effects[1]. |
| Name | SELATINIB |
|---|---|
| Synonym | More Synonyms |
| Description | Selatinib is a reversible and orally active dual EGFR and ErbB2 inhibitor with IC50s of 13 nM and 22.5 nM, respectively. Selatinib has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR:13 nM (IC50) ErbB2:22.5 nM (IC50) |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 740.5±60.0 °C at 760 mmHg |
| Molecular Formula | C29H26ClFN4O3S |
| Molecular Weight | 565.06 |
| Flash Point | 401.6±32.9 °C |
| Exact Mass | 564.139832 |
| LogP | 4.81 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.676 |
| 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfinyl)ethyl]amino]methyl]-2-furanyl]- |
| 6TLR8U8O3C |
| N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfinyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine |
| SELATINIB |
| UNII:6TLR8U8O3C |